We’re proud to support:
About Swedencare
Vetio is a subsidiary of Swedencare, a listed company on NASDAQ First North Growth Market, Stockholm, Sweden, that specializes in pet healthcare and produces, markets, and sells premium products in the global and fast-growing market for companion animals. Swedencare has a wide range of strong brands and products within most therapy areas, including NaturVet®, nutravet®, Pet MD®, Stratford®, RX Vitamins® as well as the leading oral care brand ProDen PlaqueOff®. Swedencare’s headquarter is in Malmö, Sweden with 18 group companies and 5 production facilities located in eight countries with nearly 500 employees. Swedencare’s sales have increased significantly over the last few years with strong margins and profits with products sold in approximately fifty markets worldwide.
Please visit us at www.swedencare.com
New at Vetio
-
Vetio receives Intention to Grant from the European Patent Office (EPO) and Notice of Allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew for Veterinary Applications
Montreal, Quebec (June 28, 2022) Vetio has received an Intention to Grant from the European Patent Office (EPO) and a […]
-
Vetio completes Jupiter, FL Supplement Manufacturing, R&D Laboratory and Warehouse Facilities Expansion ahead of schedule
St. Louis, MO (December 14, 2021) Vetio has completed the 35,000 square foot expansion of its Jupiter, FL site with […]
-
Vetio expands its FlavorPal™ line with new palatants to address changing market needs in Animal Health
St. Louis, MO (August 30, 2021) – Vetio is excited to announce the introduction of several new palatants under its […]
-
Swedencare AB (publ) acquires leading North American Animal Health CDMO-group and plan to initiate a new share issue
Swedencare AB (publ) (”Swedencare”) acquires the US-based Vetio. Vetio is the leading Animal Health Contract Development Manufacturing Organization (CDMO) in […]
-
Vetio Expanding its Jupiter, FL Location with New Solid Dosage Supplement Manufacturing, R&D Laboratory and Warehouse Facilities
St. Louis, MO (April 12, 2021) – Vetio is proud to announce the expansion of its Jupiter, FL site with […]
-
Vetio Awarded Cannabis Research License from Health Canada, Begins Development of Cannabis-Based Veterinary Drug Products in Montreal
St. Louis, MO (February 17, 2020) – Vetio, a contract development and manufacturing organization dedicated to Animal Health, has been […]
-
Vetio celebrates women making a difference in animal health
Vetio is very proud of all of the nominees for this year’s Feather in Her Cap award, which recognizes women […]
-
Vetio Animal Health completes plant expansion in Montreal, QC
MONTREAL, QC (August 1, 2019) – Vetio is proud to announce the completion of its Montreal plant expansion to accommodate […]
-
Tropichem and TetraGenx announce corporate name change to Vetio Animal Health
ST. LOUIS, MO (November 1, 2018) – Tropichem is proud to announce the unification of its businesses under the new […]
-
Tropichem Research Labs, LLC Acquires TetraGenx, Inc.
ST. LOUIS (March 26, 2018) – Tropichem Research Labs, LLC has acquired Montreal, Quebec-based TetraGenx (TGX), a leading independent animal […]
-
Tropichem Research Labs named Preferred Supplier by the National Animal Supplement Council
NEW ORLEANS, LA (May 19, 2017) – Tropichem Research Labs, LLC has been named a Preferred Supplier by the National […]
How can we help you?
Please contact us and let us know how we can leverage our animal health knowledge and CDMO proficiency to help you actualize animal health.